Cheng Jing
Cheng Jing, masanin kimiyya wanda tawagarsa suka kirkiro "guntu" na DNA na farko na kasar Sin don gano SARS shekaru 17 da suka gabata, yana ba da gudummawa sosai ga yakin da ake yi da barkewar COVID-19.
A cikin kasa da mako guda, ya jagoranci wata kungiya don haɓaka kayan aikin da za su iya gano ƙwayoyin cuta guda shida a lokaci guda, gami da COVID-19, tare da biyan buƙatun gaggawa na asibiti.
An haife shi a shekarar 1963, Cheng, shugaban kamfanin kimiyyar halittu na CapitalBio Corp, mataimaki ne ga majalisar wakilan jama'ar kasar Sin, kuma masani na Kwalejin Injiniya ta kasar Sin.
A ranar 31 ga Janairu, Cheng ya sami kira daga Zhong Nanshan, wani ƙwararren masani kan cututtukan numfashi, game da cutar sankarau ta coronavirus, in ji wani rahoto na Kimiyya da Fasaha Daily.
Zhong ya gaya masa game da matsalolin da ke faruwa a asibitoci game da gwajin kwayoyin acid.
Alamomin COVID-19 da mura iri ɗaya ne, wanda ya sa ingantacciyar gwaji ta fi mahimmanci.
Gano kwayar cutar da sauri don ware marasa lafiya don ƙarin magani da rage kamuwa da cuta yana da mahimmanci don shawo kan barkewar cutar.
A haƙiƙa, Cheng ya riga ya kafa ƙungiyar da za ta gudanar da bincike kan gwajin cutar coronavirus kafin ya sami kira daga Zhong.
Tun da farko, Cheng ya jagoranci tawagar daga jami'ar Tsinghua da kamfanin su zauna a dakin gwaje-gwaje dare da rana, suna yin cikakken amfani da kowane minti don kera sabon guntu DNA da na'urar gwaji.
Cheng yakan sami noodles nan take don abincin dare a lokacin.Yakan kawo kayansa kowace rana don su kasance a shirye su je “yaƙin” a wasu garuruwa.
"Mun dauki makonni biyu don samar da kwakwalwan DNA don SARS a 2003. A wannan lokacin, mun yi kasa da mako guda," in ji Cheng.
"Idan ba tare da ƙwararrun ƙwararrun da muka tara a cikin shekarun da suka gabata da kuma ci gaba da tallafa wa ƙasar nan ba, ba za mu iya kammala aikin cikin sauri ba."
Guntuwar da aka yi amfani da ita don gwada ƙwayar cutar ta SARS na buƙatar sa'o'i shida don samun sakamako.Yanzu, sabon guntu na kamfanin na iya gwada ƙwayoyin cuta na numfashi guda 19 a lokaci ɗaya cikin sa'o'i ɗaya da rabi.
Ko da yake ƙungiyar ta rage lokacin bincike da haɓaka guntu da na'urar gwaji, ba a sauƙaƙe tsarin yarda ba kuma ba a rage daidaito kwata-kwata.
Cheng ya tuntubi asibitoci hudu don gwaje-gwajen asibiti, yayin da ma'aunin masana'antu ya kai uku.
Cheng ya ce "Mun fi natsuwa fiye da na karshe, muna fuskantar annobar.""Idan aka kwatanta da 2003, ingancin bincikenmu, ingancin samfura da ƙarfin masana'antu duk sun inganta sosai."
A ranar 22 ga Fabrairu, kit ɗin da ƙungiyar ta haɓaka ta sami amincewar Hukumar Kula da Kayayyakin Kiwon Lafiya ta ƙasa kuma an yi amfani da ita cikin sauri a layin gaba.
A ranar 2 ga Maris, shugaban kasar Sin Xi Jinping ya duba birnin Beijing domin yaki da cututtuka da kuma rigakafin kimiyya.Cheng ya ba da rahoto na mintuna 20 kan yadda ake amfani da sabbin fasahohin wajen rigakafin cututtuka da kuma nasarorin bincike na na'urorin gano kwayoyin cutar.
An kafa shi a shekara ta 2000, Babban Babban Kamfanin CapitalBio Corp's core subsidiary CapitalBio Technology yana cikin yankin raya tattalin arziki da fasaha na Beijing, ko birnin E-Town.
Kimanin kamfanoni 30 a yankin sun shiga kai tsaye a yakin da ake yi da cutar ta hanyar haɓakawa da kera kayan aikin kamar injinan numfashi, robobin tattara jini, na'urorin tsarkake jini, wuraren CT scan da magunguna.
A cikin tarukan biyu na bana, Cheng ya ba da shawarar cewa, kasar ta hanzarta kafa hanyar sadarwa ta fasaha kan manyan cututtuka masu yaduwa, wadanda za su iya saurin mika bayanai game da cutar da marasa lafiya ga hukumomi.
Lokacin aikawa: Juni-12-2020